CNE0000018X6
CNE0000018X6
HUBEI JUMPCAN PHARMACEUTICAL CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 6.218.642.451 | 8.016.894.757 | 22.4% |
| Cost of Revenue | 1.308.731.494 | 1.663.540.787 | 21.3% |
| Gross Profit | 4.909.910.957 | 6.353.353.970 | 22.7% |
| 3.032.685.907 | 3.933.609.357 | 22.9% | |
| Operating Income | 1.877.225.051 | 2.419.744.614 | 22.4% |
| Pretax Income | 2.162.256.551 | 2.978.246.259 | 27.4% |
| Net Income Common Stockholders | 1.777.852.640 | 2.531.554.060 | 29.8% |
| -- | -- | -- | |
| -- | -- | -- |